Peter Fasolo net worth and biography

Peter Fasolo Biography and Net Worth

Peter M. Fasolo is Executive Vice President, Chief Human Resources Officer, responsible for global talent, recruiting, diversity and inclusion, compensation, benefits, employee relations and all aspects of the human resources agenda for the Company. He is a member of the Executive Committee, Management Compensation Committee, and Chairman of the Pension and Benefits Committee.

Peter first joined Johnson & Johnson in 2004 as Worldwide Vice President, Human Resources for Cordis Corporation. He was then named Vice President, Global Talent Management, with responsibility for executive assessment and development. He left Johnson & Johnson in 2007 to join Kohlberg Kravis Roberts & Co. (KKR) as Chief Talent Officer for the portfolio companies owned by the firm. He returned to Johnson & Johnson in September 2010 as Vice President, Global Human Resources.

Peter has more than 25 years of global experience in healthcare, having spent 13 years with Bristol-Myers Squibb in executive level, human resource roles in the pharmaceutical, medical devices and consumer segments. He serves on the Boards of the Human Resources Policy Association in Washington, D.C., Tufts University and Save the Children and was named a Fellow of the National Academy of Human Resources in 2017.

Peter earned a Ph.D. in Organizational Behavior from the University of Delaware, a Master of Arts degree in Industrial Psychology from Fairleigh Dickinson University and a Bachelor of Arts degree in Psychology from Providence College.

What is Peter Fasolo's net worth?

The estimated net worth of Peter Fasolo is at least $18.76 million as of October 24th, 2022. Dr. Fasolo owns 114,676 shares of Johnson & Johnson stock worth more than $18,755,260 as of February 6th. This net worth approximation does not reflect any other assets that Dr. Fasolo may own. Learn More about Peter Fasolo's net worth.

How do I contact Peter Fasolo?

The corporate mailing address for Dr. Fasolo and other Johnson & Johnson executives is ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK NJ, 08933. Johnson & Johnson can also be reached via phone at (732) 524-0400. Learn More on Peter Fasolo's contact information.

Has Peter Fasolo been buying or selling shares of Johnson & Johnson?

Peter Fasolo has not been actively trading shares of Johnson & Johnson in the last ninety days. Most recently, Peter Fasolo sold 29,275 shares of the business's stock in a transaction on Monday, October 24th. The shares were sold at an average price of $171.36, for a transaction totalling $5,016,564.00. Following the completion of the sale, the vice president now directly owns 114,676 shares of the company's stock, valued at $19,650,879.36. Learn More on Peter Fasolo's trading history.

Who are Johnson & Johnson's active insiders?

Johnson & Johnson's insider roster includes Dominic Caruso (VP), Robert Decker (CAO), Joaquin Duato (CEO & Director ), Peter Fasolo (VP), Alex Gorsky (CEO), William Hait (Insider), Ronald Kapusta (CAO), Ashley McEvoy (EVP), Thibaut Mongon (VP), William Perez (Director), Michael Sneed (COO), Paulus Stoffels (VP), Jennifer Taubert (EVP), Kathryn Wengel (EVP), Joseph Wolk (CFO), and Joseph Wolk (Exec. VP & CFO ). Learn More on Johnson & Johnson's active insiders.

Are insiders buying or selling shares of Johnson & Johnson?

During the last year, insiders at the sold shares 13 times. They sold a total of 402,592 shares worth more than $70,380,755.50. The most recent insider tranaction occured on December, 13th when CFO Joseph J Wolk sold 14,781 shares worth more than $2,654,667.60. Insiders at Johnson & Johnson own 0.4% of the company. Learn More about insider trades at Johnson & Johnson.

Information on this page was last updated on 12/13/2022.

Peter Fasolo Insider Trading History at Johnson & Johnson

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/24/2022Sell29,275$171.36$5,016,564.00114,676View SEC Filing Icon  
10/19/2022Sell22,864$164.50$3,761,128.00114,676View SEC Filing Icon  
12/4/2018Sell166,695$146.41$24,405,814.95155,540View SEC Filing Icon  
2/3/2016Sell151,385$104.12$15,762,206.2037,735View SEC Filing Icon  
3/14/2014Sell6,824$93.15$635,655.6015,647View SEC Filing Icon  
See Full Table

Peter Fasolo Buying and Selling Activity at Johnson & Johnson

This chart shows Peter Fasolo's buying and selling at Johnson & Johnson by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Johnson & Johnson Company Overview

Johnson & Johnson logo
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Read More

Today's Range

Now: $163.36
Low: $163.10
High: $164.85

50 Day Range

MA: $174.35
Low: $162.00
High: $180.25

2 Week Range

Now: $163.36
Low: $155.72
High: $186.69

Volume

7,005,315 shs

Average Volume

8,098,866 shs

Market Capitalization

$427.10 billion

P/E Ratio

24.24

Dividend Yield

2.75%

Beta

0.54